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The Myosin Start-of-Power Stroke State and How Actin Binding Drives
the Power Stroke
Matthias Preller1, Kenneth C. Holmes2.
1Hannover Medical School, Hannover, Germany, 2Max Planck Institute for
Medical Research, Heidelberg, Germany.
We propose that on binding to actin at the start of the power stroke the myosin
cross-bridge takes on the rigor configuration at the actin interface. Starting from
the pre-power stroke state, this can be achieved by a small movement (16 rota-
tion) of the lower 50K domain without twisting the central b-sheet or opening
switch-1 or switch-2. The movement of the lower 50K domain puts a strain on
the W-helix. This strain tries to twist the b-sheet, which could drive the power
stroke. This would provide a coupling between actin binding and the execution
of the power stroke. During the power stroke the b-sheet twists, moving the P-
loop away from switch-2, which opens the nucleotide binding pocket and sep-
arates ADP from Pi. The power stroke is different from the recovery stroke
because the upper and lower 50K domains are tethered in the rigor
configuration.
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The Myosin Inhibitor Blebbistatin Stabilizes the Super-Relaxed State in
Skeletal Muscle
Clyde Wilson1, Nariman Naber1, Edward Pate2, Roger Cooke1.
1Biochem/Biophys, Univ California, San Francisco, CA, USA,
2Bioengineering, Washington State University, Pullman, WA, USA.
The super-relaxed state of myosin (SRX) in which the myosin ATPase activity
is strongly inhibited has been observed in a variety of muscle types. It has been
proposed that myosin heads in this state are inhibited by binding to the core of
the thick filament in a structure known as the "interacting-heads motif". The
myosin inhibitor blebbistatin has been shown in structural studies to stabilize
the interacting-heads motif. Here we have utilized measurements of single
ATP turnovers to show that blebbistatin also stabilizes the SRX in both fast
and slow skeletal muscle. We find that blebbistatin is more effective in stabi-
lizing the SRX in slow skeletal fibers than in fast skeletal fibers. In the absence
of blebbistatin, the SRX is destabilized if the myosin heads are not relaxed, e.g.
rigor, rigor-ADP or activated. In the presence of blebbistatin the SRX is stable
even in these conditions. A similar stability of the SRX is seen in tarantula fi-
bers in the absence of blebbistatin. We show that spin-labeled nucleotides have
an oriented spectrum in the SRX in slow skeletal muscle in the presence of
blebbestatin that is similar to that observed in relaxed tarantula fibers in the
absence of blebbistatin. This observation shows that the structure of the SRX
is similar in different muscle types and in the presence and absence of blebbis-
tatin. The conformation of the nucleotide site in the SRX is closed, with a
conformation similar to that seen in other myosin nucleotide states as measured
by the mobility of spin probes bound at the active site.
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Attached Molecular Motor in Trapped Single Molecule Assay as a
Bi-Dimensional Brownian Multi-Stable System
Lorenzo Marcucci, Toshio Yanagida.
Osaka University, Suita (Osaka), Japan.
To elucidate the physical properties of the force generation mechanism in mo-
lecular motors, we have obtained an analytical solution of the bi-dimensional
Fokker-Plank equation which describes a common setup used in single mole-
cule experiments. As a first application of this general result, we have shown
that the size of the trapping system affects the dwell time of a multi-stable
particle linearly. A quantitative application to skeletal actomyosin complex,
using direct observation of force generation
dynamics in the literature, shows that the
size of the trapping system used was impor-
tant for increasing the dwell time of the
myosin head stable states to an observable
time scale.793-Pos Board B548
Direct Observation of Phosphate Inhibiting the Force-Generating Capac-
ity of a Mini-Ensemble of Myosin Molecules
Sam Walcott1, Matthew Turner2, Mike Woodward2, Edward P. Debold2.
1Mathematics, University of California, Davis, CA, USA, 2Kinesiology,
University of Massahcusetts, Amherst, MA, USA.
Elevated levels of phosphate (Pi) reduce isometric force, providing support
for the notion that the release of Pi from myosin is closely associated withthe generation of muscular force. Pi is thought to rebind to actomyosin in an
ADP-bound state and reverse the force-generating steps, including the rotation
of the lever arm (i.e. the powerstroke). Despite extensive study this mechanism
remains controversial in part because it fails to explain the effects of Pi on
isometric ATPase and unloaded shortening velocity. To gain new insight into
this process, we determined the effect of Pi on the force-generating capacity
of a small ensemble of myosin (~12 myosin heads) using a three-bead laser
trap assay. In the absence of Pi, myosin pulled the actin filament an average dis-
tance of 545 4nm, translating into an average peak force of 1.2pN. By contrast
in the presence of 30mM Pi, myosin displaced the actin filament by only 135
1nm, generating just 0.2pN of force. The elevated Pi also caused a>65% reduc-
tion in binding event lifetime, suggesting that Pi induces premature detachment
from a strongly-bound state. Definitive evidence of a Pi-induced powerstroke
reversal was not observed therefore we determined if a branched kinetic model
in which Pi induces detachment from a strongly-bound, post-powerstroke state
could explain these observations. The model was not only able to accurately
reproduce the present data but it was also able to reproduce the effect of Pi
on both isometric ATPase in muscle fibers and actin filament velocity in a
motility assay. The ability of the model to capture the present as well as pre-
vious findings suggests that Pi-induced inhibition of force may proceed along
a different kinetic pathway from force-generation.
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Understanding the Effects of Cardiomyopathy Causing Mutations on
Human Beta Cardiac Myosin Biomechanical Function
Suman Nag, Ruth Sommese, Jongmin Sung, Elizabeth Choe,
Masataka Kawana, Carol Cho, Rebecca Taylor, Chao Liu, Shirley Sutton,
Kathleen Ruppel, James Spudich.
Department of Biochemistry, Stanford University, Stanford, CA, USA.
Cardiomyopathy is one of the leading causes of sudden cardiac death across the
developed world. Over the last twenty years numerous single point mutations in
the cardiac contractile apparatus have been implicated in hypertrophic and
dilated cardiomyopathy (HCM or DCM), out of which nearly 40% of them
are housed in the human b-cardiac myosin. Nonetheless, the underlying molec-
ular effects of most of these mutations remain elusive. The cardiac muscle
cyclically contracts under varying loads and it is likely that the mutations in
the b-cardiac myosin affect the power output of the heart. We hypothesize
that these mutations cause a fundamental mechanistic change in the power
output of the cardiac myosin contractile system by either altering force or ve-
locity of contraction, which ultimately compromises heart function and results
in the clinical phenotypes.
Using a combination of biochemistry and single molecule spectroscopy we
show that two HCM-causing mutations (R403Q and R453C) in a truncated
version of human b-cardiac myosin ending after the essential light chain (1-
808) cause an increase in the power output by two different mechanisms. For
R403Q we see a ~20% increase in the maximum unloaded velocity, whereas
for R453C the major change is a ~50% increase in the intrinsic force generated
by a single myosin head. On the other hand, with the DCM-causing S532P b-
cardiac myosin mutant both unloaded velocity and intrinsic force is decreased
as compared to the wild type, predicting a lower power output. These results
indicate that distinct molecular mechanisms for altering power output are oper-
ative for different cardiomyopathy-causing mutants. Work is currently being
performed to understand these and other cardiomyopathy-causing mutations
using an extended version of the human b-cardiac myosin molecule (1-843)
with both human light chains.
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Optical Trapping Shows a 3-Fold Increase in Myosin Head Stiffness by the
FHC-Mutation R723G in the b-Cardiac Myosin Heavy Chain
Christoph Werkman1, Nils Hahn1, Antonio Francino2,
Francesc Navarro-Lope´z2, Theresia Kraft1, Walter Steffen1,
Bernhard Brenner1.
1Molecular and Cell Physiology, Hannover Medical School, Hannover,
Germany, 2Hospital Clinic, University of Barcelona, Barcelona, Spain.
Missense mutations in the b-cardiac myosin heavy chain (b-MyHC) are the
most frequent cause of Familial Hypertrophic Cardiomyopathy (FHC). For
these mutations mutant and wildtype b-MyHC are co-incorporated in the
contractile apparatus, and direct functional effects of such mutations presum-
ably trigger development of the FHC-phenotype. In M. soleus biopsies of
affected patients we previously found increased isometric force generation
for the converter mutation R723G, most likely due to increased stiffness of
the myosin head domain. Quantification of the increase in head stiffness
from fiber studies, however, was complicated by filament compliance, as
well as non-equal and variable co-expression of mutant and wildtype protein
in the tissue samples.
Sunday, February 16, 2014 157aIn the present work we directly determined stiffness of individual myosin heads
isolated fromM. soleus tissue samples of affected patients using the three-bead
optical trapping assay. Since each assay contained mutant and wildtype head
domains, stiffness of individual heads with and without the R723G mutation
could directly be compared. We determined head stiffness by imposing trian-
gular stage displacements and recording bead displacements during binding
events, taking into account compliance of the actin-bead link determined by
the variance-Hidden-Markov method (Smith et al., BJ 2001). We found two
populations of head domains, one with a head stiffness of 0.39 5
0.24 pN/nm the other with an about 3-fold higher stiffness. The low value is
close to our previous optical trapping with b-MyHC (0.38 5 0.06 pN/nm;
Brenner et al., JMRCM 2012), the about 3-fold increase in head stiffness agrees
well with our previous estimate from rigor stiffness in fibers with the same mu-
tation (Seebohm et al., BJ 2009) while the absolute value of head stiffness from
fibers was about 25% lower than determined here.
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Position of Phenylalanine in the Relay Loop is Important for Myosin
Motor Action
Jinghua Ge1,2, Yaroslav V. Tkachev1,3, Yuri E. Nesmelov1,2.
1Department of Physics and Optical Science, University of North Carolina at
Charlotte, Charlotte, NC, USA, 2Center for Biomedical Engineering and
Science, University of North Carolina, Charlotte, NC, USA, 3Engelhardt
Institute of Molecular Biology RAS, Moscow, Russian Federation.
We have scanned phenylalanine in the relay loop of Dictyostelium discoideum
myosin to study the role of the relay loop in the myosin ATPase actin activa-
tion. It is known that C-terminus of the relay loop is on the actin binding inter-
face. Myosin crystal structures show that F506 of the relay loop interacts with
F487 of the relay helix in the post-recovery stroke structural state. This inter-
action is absent in the pre-recovery stroke state due to the linear shift of the
relay loop along the relay helix. We hypothesized that actin binding facilitates
this conformational change in the relay loop-helix region, thus activating
myosin ATPase rate. The goal of the phenylalanine scan was to simulate the
loop-helix shift and populate myosin pre- or post-recovery stroke structural
states, mimicking proposed effect of actin binding. Two myosin mutants
were designed (F506A:D505F and F506A:G507F), along with the wild type
myosin (F506) placing phenylalanine in the three consecutive positions within
the relay loop. We have used transient time-resolved FRET, myosin intrinsic
fluorescence, pyrene labeled actin, and chemical quench to characterize myosin
kinetics in detail and conclude on the role of F506 in myosin relay loop. Sup-
ported by NIH AR59621.
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Role of the Coil-Helix Transition within Loop2 in Cardiac Myosin Kinetics
Modulation
Yaroslav V. Tkachev1,2, Yuri E. Nesmelov2.
1Engelhardt Institute of Molecular Biology RAS, Moscow, Russian
Federation, 2University of North Carolina, Charlotte, Charlotte, NC, USA.
We have used Molecular Dynamics simulations to examine structural differ-
ences of cardiac alpha and beta myosin isoforms, potentially leading to their
differences in kinetics. Cardiac myosin isoforms are intensively studied due
to correlation between elevated expression level of slower beta isoform and
the heart failure. Relationship between kinetic properties of specific isoform
and the heart function leads to the new strategy in the failing cardiac muscle
treatment, direct myosin activation. Considering myosin head as the potential
drug target, it is important to know how different structural elements of the
molecule regulate its kinetics.
Loop2 (25k-50k loop) connects two domains in myosin heavy chain subfrag-
ment S1. Studies of chimeric proteins with interchanged Loop2 showed mod-
ulation of protein kinetics and in vitro motility. It was speculated that the
major affecter of myosin kinetics is the length of the Loop 2. We have con-
structed models of alpha and beta cardiac S1 isoforms using available X-ray
structure of beta isoform and homology modeling. Trajectories of 0.5us
length in explicit solvent for each isoform were calculated. Conformational
analysis revealed several regions (including Loop2), adopting significantly
different conformations amongst alpha and beta isoforms. The terminal re-
gions of Loop2 in alpha myosin undergo coil-to-helix transitions. This pro-
cess correlates with the breakdown of salt bridges, coupling Loop2 to the
7-stranded beta sheet in the core of myosin. In contrast, these salt bridges
are conserved in the beta myosin isoform. Loop2 is connected to helices
attached to P-loop and switch II loop within myosin active site. We conclude
that observed coil-to-helix transition within Loop2 of alpha cardiac myosin
decouples structural elements of the active site and the 7-stranded beta sheet,
thus modulating kinetics of ATP hydrolysis and ADP release. Supported by
NIH AR59621.798-Pos Board B553
AKineticModel that Explains the Transient and Steady State Responses to
Mechanical and Chemical Steps Applied to CaDD Activated Skinned
Fibers from Skeletal Muscle
Vincenzo Lombardi, Marco Linari, Marco Caremani, Mario Dolfi.
Biology, University of Florence, Firenze, Italy.
Force and shortening in muscle are generated by ATP-driven working strokes
of myosin II motors, during their cyclic interactions with the actin filament.
In vitro and in situ studies suggest that the working stroke is associated
with the release of phosphate (Pi). We used nanometer-microsecond me-
chanics on skinned muscle fibers from rabbit psoas (2.4 mm sarcomere length,
12 C) to record the velocity transient following a force step and found that
the early rapid shortening, which represents the mechanical manifestation of
the working stroke, is not affected by the increase in [Pi], while the subse-
quent transition to the steady shortening velocity is accelerated and the steady
power at high loads is reduced. A new chemo-mechanical model has been
proposed that reproduces the transient and steady state responses by assuming
that biochemical and mechanical steps are not tightly coupled: (i) the release
of the hydrolysis products (Pi and ADP) from the catalytic site of the myosin
motor can occur at any stage of the working stroke and (ii) a myosin motor, in
an intermediate state of the working stroke, can slip to a second actin mono-
mer (the next monomer away from the center of the sarcomere) before termi-
nating the biochemical cycle. This model explains the efficient action of
muscle molecular motors working as an ensemble. Here we demonstrate the
model ability to fit the force transients elicited by jumps in either [ATP]
(Goldman et al., Nature 300, 701-705, 1982; Dantzig et al., J. Physiol. 432,
639-680, 1991) or [Pi] (Dantzig et al., J. Physiol. 451, 247-278, 1992;
Homsher et al., Biophys. J. 72, 1780-1791, 1997). Supported by MIUR-
PRIN and ECRF-2012 (Italy).
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Kinetic Characterization of Interactions between Stabilized Smooth
Muscle Myosin Filaments and Actin
Brian D. Haldeman, Richard Brizendine, Josh E. Baker, Christine R. Cremo.
Biochemistry, University of Nevada, Reno, Reno, NV, USA.
Using our previously described EDC-cross-linked smooth muscle myosin
(SMM) filaments that are stable to ATP-induced depolymerization, we
measured kinetic parameters of the SMM filament interactions with actin
comparing the filamentous physiological state with monomeric forms of
SMM. We use stopped-flow spectrometry, actin-activated steady state Mg-
ATPase, and in vitro motility assays to measure the fundamental kinetic differ-
ences between SMM monomers and filaments. Using stopped-flow, we show
that the apparent second order rate constant for ATP binding to the complex
of pyrene-actin with SMM filaments is 0.21 mM-1s-1, similar to HMM mono-
mers with two heads, at 0.46 mM-1s-1, and single-headed S1 at 0.47 mM-1s-1.
Using TIRF microscopy of filaments bound to surface-attached F-actin, we
show ATP decreases the number of unphosphorylated SMM filaments bound
per mm actin, giving an apparent KATP of 4.8 mM. We show that the ATP con-
centration that gives half-maximal velocities of actin moving over surface-
attached phosphorylated SMM monomers is 21.2 mM (KATP). Using
inverted-geometry to measure the velocities of phosphorylated SMM filaments
moving over surface-attached actin gave a much lower KATP ¼ 8.5 mM.
Actin-activated steady-state Mg-ATPase of phosphorylated filaments gave a
KATP ¼ 9.2 mM. The similarities in the two KATPs for filaments suggest
that filament velocities and ATPase are limited by the same kinetic step, which
best fits an attachment-limited over a detachment-limited model. Using TIRF,
we show that phosphorylated SMM filaments move over surface-attached actin
filaments until they reach the ends from which they do not detach, even upon
dephosphorylation of the SMM. This behavior is specific to SMM filaments
since skeletal filaments readily detach from actin filament ends. These obser-
vations suggest that phosphorylated SMM filaments that have been dephos-
phorylated are in a different state than unphosphorylated filaments in the
presence of ATP.
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Evidence for the Presence of AM-ADP Myosin Heads in Rigor Muscle
Fibers: Its Implication of the State of Myosin Heads after the End of
Powerstroke
Haruo Sugi1, Karina Hajar2, Kazushige Kimura2, Takakazu Kobayashi2,
Seiryo Sugiura3.
1Teikyo University, Niizashi, Saitamaken, Japan, 2Shibaura Institute of
Technology, Tokyo, Japan, 3University of Tokyo, Tokyo, Japan.
It is generally believed that, during muscle contraction, myosin heads (M) ex-
tending from myosin filaments bind with actin filaments (A) and perform
powerstrokes associated with reaction, AM-ADP-Pi /AMþPi þ ADP. The
